The Global Preclinical Data Forum, in collaboration with Cohen Veterans Bioscience, the Partnership for Assessment and Accreditation of Scientific Practice (PAASP) and the European College of Neuropsychopharmacology (ECNP), announce the opening of submissions for the 2024 Best Negative Data Prize in Preclinical Neuroscience. 

The primary aim of the prize, which was first awarded in 2018, has been to raise awareness about the importance of publishing all well-conducted studies, regardless of the outcome and not just the headline-grabbing positive results.  When researchers fail to publish negative findings, an important part of the complete scientific knowledge is lost, which could lead to unnecessary duplication of research efforts and potential loss of time and money. 

The call for submissions for the 2024 Best Negative Data Prize in Preclinical Neuroscience closes on April 30, 2024. The award itself includes waived registration fee to attend the 2024 ECNP Congress fee and travel/accommodation support available through the generous sponsorship provided by ECNP and will be awarded at the 37th ECNP Congress in Milan, Italy, September 21-24 2024.

Full details about the criteria for submission and how to apply can be found at: https://www.preclinicaldataforum.org/negative-prize/